'Peter johnson' presentation slideshows

Disclaimer

Disclaimer. The information in this presentation does not constitute an offer to sell or an invitation to buy shares in George Wimpey Plc or any other invitation or inducement to engage in investment activities. Past performance cannot be relied upon as a guide to future performance. 2.

884 views • 79 slides

Disclaimer

Disclaimer. The information in this presentation does not constitute an offer to sell or an invitation to buy shares in George Wimpey Plc or any other invitation or inducement to engage in investment activities. Past performance cannot be relied upon as a guide to future performance. 2.

791 views • 79 slides

Disclaimer

Disclaimer.

745 views • 74 slides

George Wimpey Plc 2004 Preliminary Results

George Wimpey Plc 2004 Preliminary Results. Tuesday 22 February 2005. Disclaimer.

734 views • 73 slides

Disclaimer

Disclaimer.

770 views • 72 slides

Disclaimer

Disclaimer.

727 views • 72 slides

Disclaimer

Disclaimer. The information in this presentation does not constitute an offer to sell or an invitation to buy shares in George Wimpey Plc or any other invitation or inducement to engage in investment activities. Past performance cannot be relied upon as a guide to future performance. 2.

848 views • 65 slides

Disclaimer

Disclaimer. The information in this presentation does not constitute an offer to sell or an invitation to buy shares in George Wimpey Plc or any other invitation or inducement to engage in investment activities. Past performance cannot be relied upon as a guide to future performance. 2.

655 views • 65 slides

Pharma is experience challenges

Pharma is experience challenges. US $ investment hours of work experiments researchers years drug. 1,000,000,000 7,000,874 6587 423 8 1. We want to contribute. Pharma R&D is adapting for the future Focus is on: Productivity, ROI Externalization & Collaboration Diversification

611 views • 49 slides

Denise Beutel , Ph.D. Abydos Conference April 2013

313 views • 18 slides